Antiviral Nucleosides 2003
DOI: 10.1016/b978-044451319-9/50001-4
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in Antiviral Nucleosides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
3
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 329 publications
1
3
0
Order By: Relevance
“…NMR spectroscopy confirmed the formation of E isomers which is a most favored confirmation and reported in similar type of reactions (Gumina and Chu, 2003; Tenchiu et al, 2009). An excellent example of the reactivity of N - N binucleophiles is attributed in the reaction of 1 and 2 with 3-methyl-1 H -pyrazole-5-amine yielding 7 and 14 respectively.…”
Section: Introductionsupporting
confidence: 78%
“…NMR spectroscopy confirmed the formation of E isomers which is a most favored confirmation and reported in similar type of reactions (Gumina and Chu, 2003; Tenchiu et al, 2009). An excellent example of the reactivity of N - N binucleophiles is attributed in the reaction of 1 and 2 with 3-methyl-1 H -pyrazole-5-amine yielding 7 and 14 respectively.…”
Section: Introductionsupporting
confidence: 78%
“…The conditions were improved by using our previous studies (Kovalovs et al, 2013;Novosjolova et al, 2013). For the biological activity of purine nucleosides, their anticancer and antiviral activity and use as agonists and antagonists of adenosine receptors, see: Lech-Maranda et al (2006); Robak et al (2009); Gumina et al (2003); Fredholm et al (2011); Elzein & Zablocki (2008). For the structure of another 2,6-dichloropurine ribonucleoside, 9-(2 0 -deoxy-3 0 ,5 0 -di-O-4-methoxybenzoyl--d-ribofuranosyl)-2,6-dichloro-9H-purine, see: Yang et al (2012).…”
Section: Related Literaturementioning
confidence: 99%
“…well known of their biological activity: anticancer and antiviral activities, and as agonists and antagonists of adenosine receptors(Lech-Maranda et al (2006),Robak et al (2009),Gumina et al (2003),Fredholm et al (2011),Elzein & Zablocki (2008).…”
mentioning
confidence: 99%
“…1,2 It is most prevalent in Asia, Africa, Southern Europe and Latin America, where the prevalence of hepatitis B surface antigen (HBsAg) carriers in the general population ranges from 2% to 20%. 3 Interferon has been shown to be effective against HBV, but it requires inconvenient injection therapy.…”
Section: Introductionmentioning
confidence: 99%